Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 102INDUSTRY 70NIH 10NETWORK 6OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 6Adenocarcinoma of Lung 3Meningeal Carcinomatosis 2Lung Neoplasms 2Non-squamous Non-small Cell Lung Cancer 1Non-squamous Cell Non-Small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1EGFR Positive Non-small Cell Lung Cancer 1

Interventions

Gemcitabine 6Cisplatin 5Gefitinib 3Drug Therapy 3Docetaxel 3Radiotherapy 2Pemetrexed 2Paclitaxel 2Oxaliplatin 2Erlotinib Hydrochloride 2olaparib 1Watchful Waiting 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Simvastatin 1Robotic Surgical Procedures 1Risk Factors 1Radiation 1Olanzapine 1Nutrition Assessment 1Neoadjuvant Therapy 1Muscle Stretching Exercises 1Irinotecan 1Indocyanine Green 1Fish Oils 1Environmental Biomarkers 1Enteral Nutrition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Lung Neoplasms × Pemetrexed × Clear all
NCT01356368 2014-01-22

Customizing

National Guard Health Affairs

Phase 2 Terminated
3 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
44 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡